Penny Stock Millionaire

[Daley~Mail]

$VYCO .0205 x .021 --->

-200% increase in revenues in a $20B international market
-Strong international patent suite to proprietary technology
-Legit endorsement from medical and scientific community. They have Harvard Med School Professors on the advisory board
-Technology that literally restores sight to the blind and makes inoperable brain procedures possible, 2000 medical procedures already performed
- Market gaining momentum WITHOUT promo's. 14xs the average volume -Competition is largely non-existent
-VBAS lauded in peer reviewed journals at Johns Hopkin's University, Cleveland Clinic, University of Illinois as technically superior
- Over fifteen years of clinical research, it has been shown that in approximately 70% of cases patients using NovaVision's VRT system over a three to six month period experience significant recovery in at least one functional outcome. In many cases this
recovery is enough to restore lost abilities such as reading, avoiding unseen objects while walking, or in some cases even driving a car.